Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, Sold Out, 2024 Q3

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Sold out

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q3 2024: Stock JAMES HARDIE INDS PLC; Country of operation —; Class SPONSORED ADR; Shares before 39,668.
  • Q3 2024: Stock SAVERONE 2014 LTD; Country of operation —; Class SPONSORED ADS; Shares before 488,724.
  • Q3 2024: Stock ADAPTIMMUNE THERAPEUTICS PLC; Country of operation —; Class SPONDS ADR; Shares before 142,891.
  • Q3 2024: Stock SENDAS DISTRIBUIDORA S A; Country of operation —; Class SPON ADS; Shares before 10,076.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2024JAMES HARDIE INDS PLC
CUSIP 47030M106
—SPONSORED ADR39,6680-39,668$1,251,129$0-$1,251,1292024-11-14
Q3 2024SAVERONE 2014 LTD
CUSIP 80516T105
—SPONSORED ADS488,7240-488,724$199,888$0-$199,8882024-11-14
Q3 2024ADAPTIMMUNE THERAPEUTICS PLC
CUSIP 00653A107
—SPONDS ADR142,8910-142,891$139,304$0-$139,3042024-11-14
Q3 2024SENDAS DISTRIBUIDORA S A
CUSIP 81689T104
—SPON ADS10,0760-10,076$93,707$0-$93,7072024-11-14
Q3 2024MYNARIC AG
CUSIP 62857X101
—SPON ADS17,0920-17,092$68,881$0-$68,8812024-11-14
Q3 2024SO YOUNG INTERNATIONAL INC
CUSIP 83356Q108
Cayman IslandsSPONSORED ADS60,1680-60,168$64,079$0-$64,0792024-11-14
Q3 2024SMART SH GLOBAL LTD
CUSIP 83193E102
Cayman IslandsADS67,5860-67,586$57,448$0-$57,4482024-11-14
Q3 2024CHEMOMAB THERAPEUTICS LTD
CUSIP 16385C104
—SPONSORED ADS62,4020-62,402$57,410$0-$57,4102024-11-14
Q3 2024ACHILLES THERAPEUTICS PLC
CUSIP 00449L102
—SPONSORED ADS61,3910-61,391$50,034$0-$50,0342024-11-14
Q3 2024NOVONIX LIMITED
CUSIP 67010L100
AustraliaSPONSORED ADS26,8570-26,857$48,074$0-$48,0742024-11-14
Q3 2024BOQII HLDG LTD
CUSIP 09950L302
—SPON ADS NEW83,5040-83,504$44,007$0-$44,0072024-11-14
Q3 2024QIWI PLC
CUSIP 74735M108
—SPON ADR REP B30,7130-30,713$43,536$0-$43,5362024-11-14
Q3 2024REDHILL BIOPHARMA LTD
CUSIP 757468202
—SPON ADS NEW108,5700-108,570$40,247$0-$40,2472024-11-14
Q3 2024ATA CREATIVITY GLOBAL
CUSIP 00211V106
—SPONSORED ADS50,5800-50,580$39,508$0-$39,5082024-11-14
Q3 2024XTL BIOPHARMACEUTICALS LTD
CUSIP 98386D307
IsraelSPONSORED ADR NE15,4350-15,435$36,581$0-$36,5812024-11-14
Q3 2024ASLAN PHARMACEUTICALS LTD
CUSIP 04522R200
—SPON ADS NEW117,6750-117,675$35,303$0-$35,3032024-11-14
Q3 2024WATERDROP INC
CUSIP 94132V105
Cayman IslandsADS27,3570-27,357$30,913$0-$30,9132024-11-14
Q3 2024BIODEXA PHARMACEUTICALS PLC
CUSIP 59564R708
—SPON ADS NEW33,4410-33,441$29,960$0-$29,9602024-11-14
Q3 2024DUNXIN FINL HLDGS LTD
CUSIP 26605Q205
—SPONSORED ADS136,3250-136,325$25,513$0-$25,5132024-11-14
Q3 2024LIXIANG ED HLDG CO LTD
CUSIP 53934A123
—SPON ADS53,6440-53,644$20,390$0-$20,3902024-11-14
Q3 2024TUANCHE LTD
CUSIP 89856T302
—SPONSORED ADR11,0120-11,012$19,601$0-$19,6012024-11-14
Q3 2024TC BIOPHARM HOLDINGS PLC
CUSIP 87807D400
—SPONSORED ADR22,5280-22,528$18,473$0-$18,4732024-11-14
Q3 2024QUHUO LTD
CUSIP 74841Q209
—SPON ADS34,6170-34,617$15,754$0-$15,7542024-11-14
Q3 2024ZEPP HEALTH CORPORATION
CUSIP 98945L105
—SPONSORED ADS25,5420-25,542$15,325$0-$15,3252024-11-14
Q3 2024LIGHTINTHEBOX HLDG CO LTD
CUSIP 53225G102
—SPONSORED ADR15,7960-15,796$14,295$0-$14,2952024-11-14
Q3 2024PURPLE BIOTECH LTD
CUSIP 74638P109
—SPONSORED ADS24,6280-24,628$10,221$0-$10,2212024-11-14
Q3 202436KR HOLDINGS INC
CUSIP 88429K103
—SPONSORED ADS17,1170-17,117$5,667$0-$5,6672024-11-14
Q3 2024HYWIN HLDG LTD
CUSIP 44951X104
—ADS14,4890-14,489$5,462$0-$5,4622024-11-14